Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when CervoMed Inc. publishes a filing, an earnings call transcript or a press release.

Get CRVO alerts

About Mark De Rosch

Mark De Rosch is recorded as COO at Aura Biosciences, Inc. (AURA). The newest filing on record that lists Mark De Rosch as COO at Aura Biosciences, Inc. (AURA) is dated April 25, 2023. CervoMed Inc. reported in an 8-K filed April 18, 2025 that Mark De Rosch was appointed Executive Vice President, Regulatory and Government Affairs and Program Management, effective May 1, 2025. Aura Biosciences, Inc. reported in an 8-K filed April 4, 2023 that Mark De Rosch resigned as Chief Operating Officer, effective April 30, 2023. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. CervoMed Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Elisabet de los Pinos (CEO and Board Member), Natalie Holles (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer) and 7 others.

“On April 14, 2025, the Board appointed Mark De Rosch, Ph.D., FRAPS as Executive Vice President, Regulatory and Government Affairs and Program Management, effective May 1, 2025.”
CervoMed Inc. Form 8-K, filed April 18, 2025 · Read the filing
“On April 3, 2023, Mark De Rosch informed Aura Biosciences, Inc. (the "Company") of his intent to resign as Chief Operating Officer of the Company.”
Aura Biosciences, Inc. Form 8-K, filed April 4, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Aura Biosciences, Inc.

Leadership on record at CervoMed Inc.

Recent activity